Implantable stimulation device, stimulation system and method for data communication

• US 9,375,581 B2
• Filed: 02/07/2014
• Issued: 06/28/2016
• Est. Priority Date: 02/07/2013
• Status: Active Grant

• Current Assignee: Biotronik SE & Company KG
• Original Assignee: Biotronik SE & Company KG
• Inventors: Baru, Marcelo, Moulder, J. Christopher
• Primary Examiner(s): Lavert, Nicole F
• Assistant Examiner(s): MAHMOOD, NADIA AHMAD
• Application Number:
  US14/176,027
• Publication Number:
  US 20140222098A1
• Time in Patent Office: 872 Days
• Field of Search: 607/16, 607/46, 607/57
• US Class Current: 1/1
• CPC Class Codes: A61N 1/3708 for power depletion
• CPC Class Codes: A61N 1/37211 Means for communicating with stimulators
• CPC Class Codes: A61N 1/37217 characterised by the communication link, e.g. acoustic or tactile
• CPC Class Codes: A61N 1/37276 characterised by means for reducing power consumption during telemetry
• CPC Class Codes: A61N 1/375 Constructional arrangements, e.g. casings
• CPC Class Codes: A61N 1/37512 Pacemakers

Abstract

An implantable stimulation device including a stimulation module and a data communication module. The stimulation device includes electrodes to delivery stimulation pulses, a voltage source, a DC-blocking capacitor and autoshort switch. The voltage source is connected to the electrodes via stimulation-pulse-switch(s) that controls delivery pacing pulses. The DC-blocking capacitor is connected with the voltage source and an electrode. The autoshort switch allows discharging of the DC-blocking capacitor via the electrodes when closed. The data communication module includes a data transmission control module connected to the autoshort switch and/or the at least one stimulation-pulse-switch, to alternatingly open and close the autoshort switch or the at least one stimulation-pulse-switch respectively, during an autoshort period following the delivery of a stimulation pulse or during a stimulation pulse period, respectively, to modulate an autoshort pulse or a stimulation pulse peak amplitude, respectively.

Claims

1. An implantable stimulation device comprising:

at least one stimulation module;

at least two electrodes configured to allow delivery of stimulation pulses; and

,

at least one data communication module;

wherein said at least one stimulation module comprises

a voltage source,

wherein said voltage source is configured to connect to the at least two electrodes via at least one stimulation-pulse-switch that is configured to control delivery of a pacing pulse,

at least one DC-blocking capacitor connected in series with the voltage source and the at least two electrodes, and

an autoshort switch configured to allow discharging of the at least one DC-blocking capacitor via the at least two electrodes when the autoshort switch is closed;

wherein said at least one data communication module comprises at least one data transmission control module connected to the autoshort switch and is configured to

alternatingly open and close the autoshort switch during an autoshort period following the delivery of a stimulation pulse to modulate a autoshort pulse amplitude,

wherein the at least one data communication module is connected to the at least two electrodes and is further configured to sense an oscillatory electric field imposed on body tissue surrounding the implantable stimulation device, and,

wherein the data communication module further comprises a phase-locked loop (PLL) and a frequency divider, wherein the phase-locked loop is configured to lock in a frequency of the oscillatory electric field imposed on body tissue surrounding the implantable stimulation device, and wherein the frequency divider is configured to connect to the phase-locked loop and divide a frequency signal put out by the phase-locked loop.

2. The implantable stimulation device according to claim 1, wherein the at least one data transmission control module is further configured to control switching of the autoshort switch phase-synchronized with the oscillatory electric field imposed on body tissue surrounding the implantable stimulation device.

3. The implantable stimulation device according to claim 1, wherein the data communication module further comprises a band-pass filter, wherein the band-pass filter is configured to filter a signal fed to the phase-locked loop.

4. An implantable stimulation device comprising:

at least one stimulation module;

at least two electrodes configured to allow delivery of stimulation pulses; and

,

at least one data communication module;

wherein said at least one stimulation module comprises

a voltage source,

wherein said voltage source is configured to connect to the at least two electrodes via at least one stimulation-pulse-switch that is configured to control delivery of a pacing pulse,

wherein said at least one data communication module comprises at least one data transmission control module connected to the at least one stimulation-pulse-switch, and is configured to

alternatingly open and close the at least one stimulation-pulse-switch during a stimulation pulse period to modulate at least a portion of a stimulation pulse amplitude,

wherein the at least one data communication module is connected to the at least two electrodes and is further configured to sense an oscillatory electric field imposed on body tissue surrounding the implantable stimulation device, and,

wherein the data communication module comprises a phase-locked loop (PLL) and a frequency divider, wherein the phase-locked loop is configured to lock in a frequency of the oscillatory electric field imposed on body tissue surrounding the implantable stimulation device, and wherein the frequency divider is configured to connect to the phase-locked loop and divide a frequency signal put out by the phase-locked loop.

5. The implantable stimulation device according to claim 4, wherein the data transmission control module is configured to maintain an average peak amplitude of the stimulation pulse.

6. The implantable stimulation device according to claim 4, wherein the at least one data transmission control module is further configured to control switching of the at least one stimulation-pulse-switch phase-synchronized with the oscillatory electric field imposed on body tissue surrounding the implantable stimulation device.

7. The implantable stimulation device according to claim 4, further comprising four switches and a rectifier bridge, wherein the four switches and the rectifier bridge are configured to allow bi-directional current flow to generate a stimulation pulse having a modulated peak amplitude that is uni-directionally delivered to tissue via the rectifier bridge.

8. The implantable stimulation device according to claim 4, wherein the data communication module further comprises a band-pass filter, wherein the band-pass filter is configured to filter a signal fed to the phase-locked loop.

9. A data communication system comprising:

an implantable stimulation device comprising

at least one stimulation module;

at least two electrodes configured to allow delivery of stimulation pulses; and

,

at least one data communication module;

wherein said at least one stimulation module comprises

a voltage source,

 

wherein said voltage source is configured to connect to the at least two electrodes via at least one stimulation-pulse-switch that is configured to control delivery of a pacing pulse,

at least one DC-blocking capacitor connected in series with the voltage source and the at least two electrodes, and

an autoshort switch configured to allow discharging of the at least one DC-blocking capacitor via the at least two electrodes when the autoshort switch is closed;

wherein said at least one data communication module comprises at least one data transmission control module connected to the autoshort switch and is configured to

alternatingly open and close the autoshort switch during an autoshort period following the delivery of a stimulation pulse to modulate an autoshort pulse amplitude; and

,

a external device comprising at least two cutaneous electrodes;

wherein the external device further comprises at least one sensor module configured to sense one or more of alterations of body impedance and a local electric field generated by the implantable stimulation device.

10. The data communication system according to claim 9, wherein the external device further comprises a lock-in amplifier, an AM demodulator configured to demodulate amplitude-modulated signals, and an analog-to-digital converter;

wherein the analog-to-digital converter is connected to the AM demodulator and the lock-in amplifier, and

wherein the analog-to-digital converter is configured to put out a signal that represents a signal transmitted by the implantable stimulation device.